TEMBEXA
About TEMBEXA
TEMBEXA is involved in the pharmaceutical sector, where drugs are produced for various therapeutic areas including infectious diseases and other health conditions. Operations center on manufacturing processes that meet industry standards, with a focus on developing treatments for unmet medical needs. No specific founding year or geographic details are available, but the companys activities support broader healthcare supply chains through its domain-based online presence.
- SectorsHealthcare
- Acquired by Emergent BioSolutions (Sep 2022)
- Investors
- Acquired byEmergent BioSolutions
(Sep 2022)
Investors in TEMBEXA
TEMBEXA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Emergent BioSolutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vaccines for viral infections are developed by the company. | 1998 | emergentbiosolutions.com | Gaithersburg, United States |
Investor details for TEMBEXA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Similar companies to TEMBEXA
10 companies that operate in the same segment as TEMBEXA (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TEMBEXA
TEMBEXA is involved in the pharmaceutical sector, where drugs are produced for various therapeutic areas including infectious diseases and other health conditions. Operations center on manufacturing processes that meet industry standards, with a focus on developing treatments for unmet medical needs. No specific founding year or geographic details are available, but the companys activities support broader healthcare supply chains through its domain-based online presence.
TEMBEXA has 1 investor. Key investors include Emergent BioSolutions.
Yes. TEMBEXA was acquired by Emergent BioSolutions in September 2022.